Using Signature Genes to Detect Early-Stage Coronavirus and Predict Individual Outcomes

Smith Yoav, HUJI, School of Medicine - IMRIC
  • Test signature genes of hostĀ for non-invasive and early detection of Coronavirus infection, even before the infected person is symptomatic (also allowing differentiation from influenza virus infections).
  • Moreover, this unique signature can be used to predict disease outcome in infected individuals as well as predict the vulnerability to the virus in non- infected individuals. The last can be valuable for screening of vulnerable populations such as medical teams and caregivers.

Contact for more information:

Mel Larrosa
VP Business Development Healthcare
Contact ME:
All projects by:Smith Yoav (2)